Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
Knee cartilage patch study halted – early results inconclusive
Disease control TerminatedThis study tested whether a special collagen patch (Chondro-Gide®) placed over large knee cartilage injuries could help people recover as well as standard microfracture surgery for smaller injuries. The study planned to enroll 82 people aged 18–55 with knee cartilage damage, but …
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New collagen patch tested for knee cartilage repair
Disease control TerminatedThis study tested a special collagen membrane (Chondro-Gide®) to help repair damaged knee cartilage. It included 75 people aged 18-55 with moderate to severe cartilage defects. The goal was to see if the membrane safely improves cartilage healing, measured by MRI scans and knee f…
Phase: NA • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC